| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
46,059 |
39,027 |
$2.43M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
6,012 |
5,972 |
$513K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15,664 |
15,453 |
$450K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,594 |
5,543 |
$436K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,803 |
2,759 |
$218K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,736 |
1,693 |
$125K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,162 |
1,155 |
$101K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,387 |
3,309 |
$76K |
| 92551 |
|
8,659 |
8,433 |
$69K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
814 |
787 |
$60K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,033 |
2,812 |
$43K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,915 |
2,865 |
$39K |
| 0002A |
|
300 |
299 |
$15K |
| 99173 |
|
9,421 |
9,071 |
$14K |
| 0001A |
|
275 |
274 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
299 |
297 |
$9K |
| 0072A |
|
176 |
176 |
$9K |
| 94760 |
|
5,715 |
5,151 |
$7K |
| 99188 |
|
599 |
575 |
$5K |
| 0003A |
|
105 |
98 |
$5K |
| 0071A |
|
127 |
126 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
376 |
319 |
$5K |
| 86580 |
|
662 |
653 |
$5K |
| 99177 |
|
211 |
207 |
$4K |
| 99383 |
|
42 |
42 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
82 |
82 |
$3K |
| 99381 |
|
16 |
16 |
$1K |
| 99384 |
|
14 |
13 |
$1K |
| 0073A |
|
15 |
15 |
$975.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
46 |
44 |
$871.72 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$817.41 |
| 81002 |
|
196 |
189 |
$556.18 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
30 |
29 |
$472.93 |
| 94664 |
|
13 |
13 |
$189.85 |
| A7015 |
Aerosol mask, used with dme nebulizer |
29 |
28 |
$30.93 |
| 90670 |
|
882 |
834 |
$15.60 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
29 |
28 |
$4.14 |
| 91300 |
|
158 |
137 |
$0.30 |
| 90620 |
|
797 |
781 |
$0.03 |
| 90633 |
|
383 |
360 |
$0.00 |
| 90649 |
|
1,517 |
1,432 |
$0.00 |
| 90734 |
|
1,517 |
1,418 |
$0.00 |
| 90648 |
|
471 |
445 |
$0.00 |
| 90687 |
|
346 |
294 |
$0.00 |
| 90685 |
|
65 |
65 |
$0.00 |
| 90715 |
|
344 |
331 |
$0.00 |
| 90700 |
|
43 |
43 |
$0.00 |
| 90680 |
|
256 |
240 |
$0.00 |
| 90686 |
|
1,300 |
1,288 |
$0.00 |
| 90688 |
|
5,536 |
5,090 |
$0.00 |
| 90723 |
|
191 |
176 |
$0.00 |
| 90698 |
|
15 |
12 |
$0.00 |
| 90696 |
|
12 |
12 |
$0.00 |
| 90716 |
|
31 |
27 |
$0.00 |
| 91307 |
|
15 |
13 |
$0.00 |